Plaintiffs Move To Certify 4 Classes In EpiPen Breach Of Fiduciary Suit
(January 2, 2020, 5:31 PM EST) -- MINNEAPOLIS — Plaintiffs in a class action suit alleging that a number of defendants breached their fiduciary duties by increasing the cost of the EpiPen prescription maintain in a Dec. 16...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login